Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial flora of the skin lesion area are the various bacterial populations present in and around a skin lesion. Unlike a single molecular target, this term describes a complex microbial community. Its composition shifts in response to host factors (e.g., skin biogeography, immune status), lesion type, and environmental changes (wound, infection, treatment). The skin lesion flora may contain commensals (Staphylococcus epidermidis, Cutibacterium acnes, Corynebacterium spp.) and opportunistic or pathogenic species (e.g., Staphylococcus aureus, Streptococcus pyogenes, Pseudomonas aeruginosa). In healthy skin, such microbiota are protective, maintaining barrier function and competing against pathogens, but in lesions, dysbiosis (microbial imbalance) can contribute to or result from infection, impaired healing, inflammation, and disease progression. Therapeutic approaches increasingly target the skin microbiome as a community, using antibiotics, antiseptics, probiotic-based bacteriotherapies, and immunomodulators to re-balance flora and treat cutaneous diseases. However, "bacterial flora of the skin lesion area" is not a conventional molecule/receptor target, and thus the query refers to a microbial ecosystem rather than a single actionable entity.
Not applicable as a molecular target. Drugs may act by: eradicating pathogenic bacteria (antibiotics, antiseptics); modifying overall microbial composition (probiotics, bacteriotherapy); or altering local immune environment (immunomodulatory therapies, UV phototherapy).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial flora of the skin lesion area.